Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Clinical Evaluation of Phenformin (DBI) in Office Practice

Clinical Evaluation of Phenformin (DBI) in Office Practice One hundred and four diabetic patients of both sexes, ranging in age from 4 to 83 years, were studied for seven months in a private office practice to evaluate the effect of phenformin therapy. Most of these patients had had difficulty in controlling their diabetes before taking phenformin. Fair to excellent control was achieved by 91 (88%) with or without adjunctive exogenous insulin; failures which occurred in 13 cases were attributable to gastrointestinal, behavioral, or environmental difficulties. Special importance was attached to the value of combined phenformininsulin therapy in reducing the incidence and severity of hypoglycemic episodes and in improving the control of previously labile patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Clinical Evaluation of Phenformin (DBI) in Office Practice

JAMA , Volume 174 (5) – Oct 1, 1960

Loading next page...
 
/lp/american-medical-association/clinical-evaluation-of-phenformin-dbi-in-office-practice-QFEba3pnO0

References (4)

Publisher
American Medical Association
Copyright
Copyright © 1960 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1960.03030050016005
Publisher site
See Article on Publisher Site

Abstract

One hundred and four diabetic patients of both sexes, ranging in age from 4 to 83 years, were studied for seven months in a private office practice to evaluate the effect of phenformin therapy. Most of these patients had had difficulty in controlling their diabetes before taking phenformin. Fair to excellent control was achieved by 91 (88%) with or without adjunctive exogenous insulin; failures which occurred in 13 cases were attributable to gastrointestinal, behavioral, or environmental difficulties. Special importance was attached to the value of combined phenformininsulin therapy in reducing the incidence and severity of hypoglycemic episodes and in improving the control of previously labile patients.

Journal

JAMAAmerican Medical Association

Published: Oct 1, 1960

There are no references for this article.